Tag Archives: FDA

FDA Approves Lilly’s Retevmo® (Selpercatinib) for RET Fusion–Positive Locally Advanced or Metastatic Solid Tumors

On September 21, 2022, the FDA has granted regular approval to selpercatinib (Retevmo®) 40 mg and 80 mg capsules for […]

September 30, 2022

Cipla Gets the Final Approval for Generic Version of Revlimid by US FDA

On September 7’th, 2022, Cipla Ltd announced that it has received final approval for its generic version (ANDA) of Lenalidomide […]

September 12, 2022

FDA Approves Xenpozyme: The First Disease-specific Medication for Acid Sphingomyelinase Deficiency (ASMD)

On August 31, 2022, the U.S. FDA approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with […]

September 8, 2022

FDA-approved Zynteglo: Cell-based gene therapy for beta-thalassemia

The FDA approved the first cell-based therapy on 17 August 22 for the treatment of adult and pediatric patients with […]

August 22, 2022